Review



image analysis program meta morph  (universal imaging inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    universal imaging inc image analysis program meta morph
    Image Analysis Program Meta Morph, supplied by universal imaging inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/image+analysis+program+meta+morph/pmc02899449-73-14-19
    Average 90 stars, based on 1 article reviews
    image analysis program meta morph - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: comparative analysis according to the risk factor.
    Article Snippet: Osteogenic differentiation was quantified by measurement of area stained with alizarin red S by using an image analysis program (Meta Morph, Universal Imaging, Downingtown, PA).

    Staining:

    Article Title: Decreased osteogenic differentiation of mesenchymal stem cells and reduced bone mineral density in patients with adolescent idiopathic scoliosis
    Article Snippet: .. Osteogenic differentiation was quantified by measuring areas stained with alizarin red S using an image analysis program (Meta Morph, Universal Imaging, Downing-town, PA). ..



    Similar Products

    meta analysis  (Carollo Engineers)
    86
    Carollo Engineers meta analysis
    Meta Analysis, supplied by Carollo Engineers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/analysis+meta/pm42286468-367-22-0
    Average 86 stars, based on 1 article reviews
    meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    network meta analysis  (Drucker Diagnostics)
    86
    Drucker Diagnostics network meta analysis
    Network Meta Analysis, supplied by Drucker Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/analysis+meta+network/pm42260365-376-16-10
    Average 86 stars, based on 1 article reviews
    network meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    nephrology meta analysis  (Wolters Kluwer Health)
    86
    Wolters Kluwer Health nephrology meta analysis
    Nephrology Meta Analysis, supplied by Wolters Kluwer Health, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/analysis+meta/10__34067_slash_kid__0000001257-231-13-2
    Average 86 stars, based on 1 article reviews
    nephrology meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    stouffer z score meta analysis  (Stouffer Industries)
    86
    Stouffer Industries stouffer z score meta analysis
    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. <t>(c)</t> <t>Meta-analysis</t> mean fold-change <t>(Z-score)</t> per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).
    Stouffer Z Score Meta Analysis, supplied by Stouffer Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/score+z/pmc13253502-31-14-14
    Average 86 stars, based on 1 article reviews
    stouffer z score meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    stouffer meta analysis  (Stouffer Industries)
    86
    Stouffer Industries stouffer meta analysis
    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. <t>(c)</t> <t>Meta-analysis</t> mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).
    Stouffer Meta Analysis, supplied by Stouffer Industries, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/score+z/pmc13253502-2-38-38
    Average 86 stars, based on 1 article reviews
    stouffer meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    meta analysis  (Fresenius Kabi)
    86
    Fresenius Kabi meta analysis
    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. <t>(c)</t> <t>Meta-analysis</t> mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).
    Meta Analysis, supplied by Fresenius Kabi, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/10__1097_slash_aln__0000000000006163-28-32-36
    Average 86 stars, based on 1 article reviews
    meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    meta analysis  (Galectin Therapeutics)
    86
    Galectin Therapeutics meta analysis
    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. <t>(c)</t> <t>Meta-analysis</t> mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).
    Meta Analysis, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/pm42145000-605-12-2
    Average 86 stars, based on 1 article reviews
    meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    meta analysis  (Kamiya)
    86
    Kamiya meta analysis
    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. <t>(c)</t> <t>Meta-analysis</t> mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).
    Meta Analysis, supplied by Kamiya, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/analysis+meta/pm42141800-47-2-5
    Average 86 stars, based on 1 article reviews
    meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    genome wide association meta analysis  (Henkel Corporation)
    86
    Henkel Corporation genome wide association meta analysis
    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. <t>(c)</t> <t>Meta-analysis</t> mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).
    Genome Wide Association Meta Analysis, supplied by Henkel Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/analysis+association+genome+meta+wide/pm42128200-262-24-1
    Average 86 stars, based on 1 article reviews
    genome wide association meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier
    meta analysis  (American Gastroenterological Association)
    86
    American Gastroenterological Association meta analysis
    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. <t>(c)</t> <t>Meta-analysis</t> mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).
    Meta Analysis, supplied by American Gastroenterological Association, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/meta-analysis/analysis+meta/pm42115375-98-3-6
    Average 86 stars, based on 1 article reviews
    meta analysis - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. (c) Meta-analysis mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).

    Journal: Frontiers in Immunology

    Article Title: CheckDyn: a multi-cohort computational framework for profiling treatment-induced immune checkpoint dynamics and predicting adaptive resistance to immune checkpoint blockade

    doi: 10.3389/fimmu.2026.1847297

    Figure Lengend Snippet: Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. (c) Meta-analysis mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).

    Article Snippet: The CheckDyn pipeline integrates these datasets through pseudo-bulk aggregation, empirical Bayes batch correction, and Stouffer Z-score meta-analysis to quantify treatment-induced changes across a curated 38-gene checkpoint and exhaustion marker panel.

    Techniques: Transcriptomics, Functional Assay, Expressing

    Meta-analysis volcano and cross-dataset expression heatmap. (a) Meta-analysis volcano plot (3 cohorts). Genes reaching meta-padj < 0.05 (red): LAG3, PDCD1, TOX2 (top right). CD274, CD80 also approach significance. Dashed lines indicate significance thresholds. (b) Log 2 FC heatmap of significant genes per dataset. Color scale as in <xref ref-type=Figure 2a . Values are annotated per cell. LAG3 shows uniformly high log 2 FC across all three cohorts (0.49/0.76/0.74). " width="100%" height="100%">

    Journal: Frontiers in Immunology

    Article Title: CheckDyn: a multi-cohort computational framework for profiling treatment-induced immune checkpoint dynamics and predicting adaptive resistance to immune checkpoint blockade

    doi: 10.3389/fimmu.2026.1847297

    Figure Lengend Snippet: Meta-analysis volcano and cross-dataset expression heatmap. (a) Meta-analysis volcano plot (3 cohorts). Genes reaching meta-padj < 0.05 (red): LAG3, PDCD1, TOX2 (top right). CD274, CD80 also approach significance. Dashed lines indicate significance thresholds. (b) Log 2 FC heatmap of significant genes per dataset. Color scale as in Figure 2a . Values are annotated per cell. LAG3 shows uniformly high log 2 FC across all three cohorts (0.49/0.76/0.74).

    Article Snippet: The CheckDyn pipeline integrates these datasets through pseudo-bulk aggregation, empirical Bayes batch correction, and Stouffer Z-score meta-analysis to quantify treatment-induced changes across a curated 38-gene checkpoint and exhaustion marker panel.

    Techniques: Expressing

    Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. (c) Meta-analysis mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).

    Journal: Frontiers in Immunology

    Article Title: CheckDyn: a multi-cohort computational framework for profiling treatment-induced immune checkpoint dynamics and predicting adaptive resistance to immune checkpoint blockade

    doi: 10.3389/fimmu.2026.1847297

    Figure Lengend Snippet: Study overview: multi-cohort paired transcriptomics of checkpoint dynamics. (a) Study design schematic. Paired tumor biopsies were collected before and after ICB therapy (anti-PD-1 or anti-PD-1/anti-CTLA-4), and transcriptomic profiles were used for checkpoint dynamics analysis and clinical response association. (b) Dataset overview. Bar chart showing the number of paired patients (pre + post biopsies) per cohort and cancer type. n = 42 from GSE91061 (melanoma), n = 11 from Sade-Feldman2018/ GSE120575 (melanoma), n = 11 from Yost2019/ GSE123813 (BCC); total n = 64. (c) Meta-analysis mean fold-change (Z-score) per checkpoint gene across all datasets. Asterisks indicate genes reaching padj < 0.05. Genes are colored by functional category: inhibitory checkpoints (red), co-stimulatory molecules (teal), metabolic checkpoints (salmon), exhaustion markers (blue-grey). (d) Six-step analysis pipeline: data collection (4 cohorts, n = 64 paired) → pseudo-bulk aggregation and Z-score batch correction → paired DE analysis (Stouffer Z meta-analysis) → network rewiring (co-expression, hub shift) → ensemble model (AUC = 0.812, n = 38 genes) → clinical implication (combination therapy).

    Article Snippet: We integrated publicly available RNA-seq and scRNA-seq data from 64 paired tumor samples spanning melanoma, basal cell carcinoma, and non-small-cell lung cancer ( GSE91061 , GSE120575 , GSE123813 , GSE176021 ), applying pseudo-bulk aggregation, Z-score batch correction, and Stouffer meta-analysis for cross-cohort harmonization.

    Techniques: Transcriptomics, Functional Assay, Expressing

    Meta-analysis volcano and cross-dataset expression heatmap. (a) Meta-analysis volcano plot (3 cohorts). Genes reaching meta-padj < 0.05 (red): LAG3, PDCD1, TOX2 (top right). CD274, CD80 also approach significance. Dashed lines indicate significance thresholds. (b) Log 2 FC heatmap of significant genes per dataset. Color scale as in <xref ref-type=Figure 2a . Values are annotated per cell. LAG3 shows uniformly high log 2 FC across all three cohorts (0.49/0.76/0.74). " width="100%" height="100%">

    Journal: Frontiers in Immunology

    Article Title: CheckDyn: a multi-cohort computational framework for profiling treatment-induced immune checkpoint dynamics and predicting adaptive resistance to immune checkpoint blockade

    doi: 10.3389/fimmu.2026.1847297

    Figure Lengend Snippet: Meta-analysis volcano and cross-dataset expression heatmap. (a) Meta-analysis volcano plot (3 cohorts). Genes reaching meta-padj < 0.05 (red): LAG3, PDCD1, TOX2 (top right). CD274, CD80 also approach significance. Dashed lines indicate significance thresholds. (b) Log 2 FC heatmap of significant genes per dataset. Color scale as in Figure 2a . Values are annotated per cell. LAG3 shows uniformly high log 2 FC across all three cohorts (0.49/0.76/0.74).

    Article Snippet: We integrated publicly available RNA-seq and scRNA-seq data from 64 paired tumor samples spanning melanoma, basal cell carcinoma, and non-small-cell lung cancer ( GSE91061 , GSE120575 , GSE123813 , GSE176021 ), applying pseudo-bulk aggregation, Z-score batch correction, and Stouffer meta-analysis for cross-cohort harmonization.

    Techniques: Expressing